82 related articles for article (PubMed ID: 29620229)
1. miR‑22‑3p enhances multi‑chemoresistance by targeting NET1 in bladder cancer cells.
Xiao J; Niu S; Zhu J; Lv L; Deng H; Pan D; Shen D; Xu C; Shen Z; Tao T
Oncol Rep; 2018 Jun; 39(6):2731-2740. PubMed ID: 29620229
[TBL] [Abstract][Full Text] [Related]
2. NET1 Enhances Proliferation and Chemoresistance in Acute Lymphoblastic Leukemia Cells.
Sun H; Zhang Z; Luo W; Liu J; Lou Y; Xia S
Oncol Res; 2019 Aug; 27(8):935-944. PubMed ID: 31046876
[TBL] [Abstract][Full Text] [Related]
3. miR-130b promotes bladder cancer cell proliferation, migration and invasion by targeting VGLL4.
Liu X; Kong C; Zhang Z
Oncol Rep; 2018 May; 39(5):2324-2332. PubMed ID: 29512748
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
[TBL] [Abstract][Full Text] [Related]
5. MiR-34b-3p Represses the Multidrug-Chemoresistance of Bladder Cancer Cells by Regulating the CCND2 and P2RY1 Genes.
Tan Y; Zhang T; Zhou L; Liu S; Liang C
Med Sci Monit; 2019 Feb; 25():1323-1335. PubMed ID: 30778022
[TBL] [Abstract][Full Text] [Related]
6. The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer.
Li Y; Deng H; Lv L; Zhang C; Qian L; Xiao J; Zhao W; Liu Q; Zhang D; Wang Y; Yan J; Zhang H; He Y; Zhu J
Oncotarget; 2015 Apr; 6(12):10195-206. PubMed ID: 25991669
[TBL] [Abstract][Full Text] [Related]
7. miR‑214 reduces cisplatin resistance by targeting netrin‑1 in bladder cancer cells.
Liu J; Bi J; Li Z; Li Z; Liu X; Kong C
Int J Mol Med; 2018 Mar; 41(3):1765-1773. PubMed ID: 29328435
[TBL] [Abstract][Full Text] [Related]
8. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells.
Lei Y; Li B; Tong S; Qi L; Hu X; Cui Y; Li Z; He W; Zu X; Wang Z; Chen M
PLoS One; 2015; 10(2):e0117809. PubMed ID: 25658842
[TBL] [Abstract][Full Text] [Related]
9. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
[TBL] [Abstract][Full Text] [Related]
10. MiR-1307 promotes ovarian cancer cell chemoresistance by targeting the ING5 expression.
Chen WT; Yang YJ; Zhang ZD; An Q; Li N; Liu W; Yang B
J Ovarian Res; 2017 Jan; 10(1):1. PubMed ID: 28086946
[TBL] [Abstract][Full Text] [Related]
11. Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines.
Kim SH; Ho JN; Jin H; Lee SC; Lee SE; Hong SK; Lee JW; Lee ES; Byun SS
Investig Clin Urol; 2016 Jan; 57(1):63-72. PubMed ID: 26966728
[TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rh2 differentially mediates microRNA expression to prevent chemoresistance of breast cancer.
Wen X; Zhang HD; Zhao L; Yao YF; Zhao JH; Tang JH
Asian Pac J Cancer Prev; 2015; 16(3):1105-9. PubMed ID: 25735339
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
14. NF-κB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression.
Sun Y; Guan Z; Liang L; Cheng Y; Zhou J; Li J; Xu Y
Int J Oncol; 2016 Jan; 48(1):225-34. PubMed ID: 26647959
[TBL] [Abstract][Full Text] [Related]
15. The Involvement of Hepatocyte Growth Factor-MET-Matrix Metalloproteinase 1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells.
Shintani T; Kusuhara Y; Daizumoto K; Dondoo TO; Yamamoto H; Mori H; Fukawa T; Nakatsuji H; Fukumori T; Takahashi M; Kanayama H
Urology; 2017 Mar; 101():169.e7-169.e13. PubMed ID: 28013036
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1.
Cheng Y; Yang X; Deng X; Zhang X; Li P; Tao J; Lu Q
Tumour Biol; 2015 Sep; 36(10):8015-23. PubMed ID: 25967457
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
[TBL] [Abstract][Full Text] [Related]
18. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
[TBL] [Abstract][Full Text] [Related]
19. MiR-222 modulates multidrug resistance in human colorectal carcinoma by down-regulating ADAM-17.
Xu K; Liang X; Shen K; Sun L; Cui D; Zhao Y; Tian J; Ni L; Liu J
Exp Cell Res; 2012 Oct; 318(17):2168-77. PubMed ID: 22677042
[TBL] [Abstract][Full Text] [Related]
20. Neuroepithelial transforming gene 1 functions as a potential prognostic marker for patients with non-small cell lung cancer.
Fang L; Zhu J; Ma Y; Hong C; Xiao S; Jin L
Mol Med Rep; 2015 Nov; 12(5):7439-46. PubMed ID: 26459749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
